97 related articles for article (PubMed ID: 1478125)
21. Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K
Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280
[TBL] [Abstract][Full Text] [Related]
22. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
Hauf GF; Grom E; Jähnchen E; Roskamm H
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
[TBL] [Abstract][Full Text] [Related]
23. [The effect of captopril on the immediate quality of life in patients with congestive heart failure].
Han Y
Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Jun; 20(3):154-6. PubMed ID: 1289024
[No Abstract] [Full Text] [Related]
24. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
[TBL] [Abstract][Full Text] [Related]
25. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
26. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Kramer B; Topic N; Massie B
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
[No Abstract] [Full Text] [Related]
27. Acute renal effects of captopril in patients with congestive heart failure.
Ribstein J; Mimran A
J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554
[TBL] [Abstract][Full Text] [Related]
28. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
Cardiology; 1995; 86 Suppl 1():34-40. PubMed ID: 7614505
[TBL] [Abstract][Full Text] [Related]
30. Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study.
Bussmann WD; Störger H; Hadler D; Reifart N; Fassbinder W; Jungmann E; Kaltenbach M
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S50-60. PubMed ID: 2441202
[TBL] [Abstract][Full Text] [Related]
31. Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril.
Stanek B; Punzengruber C; Silberbauer K
Clin Cardiol; 1989 Feb; 12(2):97-101. PubMed ID: 2653680
[TBL] [Abstract][Full Text] [Related]
32. Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
Magnani B; Magelli C
Postgrad Med J; 1986; 62 Suppl 1():153-8. PubMed ID: 3534852
[TBL] [Abstract][Full Text] [Related]
33. A comparison of captopril and digoxin in the treatment of patients with mild-to-moderate chronic congestive heart failure.
Heck I; Lüderitz B; Müller HM; Esser H
Clin Ther; 1995; 17(2):270-9. PubMed ID: 7614527
[TBL] [Abstract][Full Text] [Related]
34. [Effect of captopril on the life expectancy of patients with chronic heart failure].
Kleber FX
Herz; 1987 Dec; 12 Suppl 1():38-45. PubMed ID: 3325395
[TBL] [Abstract][Full Text] [Related]
35. Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure.
Anand I; Chandrashekhan Y; De Giuli F; Pasini E; Mazzoletti A; Confortini R; Ferrari R
Cardiovasc Drugs Ther; 1998 Jul; 12(3):291-9. PubMed ID: 9784909
[TBL] [Abstract][Full Text] [Related]
36. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
Corbalán R; Jalil J; Chamorro G; Casanegra P; Valenzuela P
Am J Cardiol; 1990 Mar; 65(9):644-9. PubMed ID: 2178384
[TBL] [Abstract][Full Text] [Related]
37. Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril.
Wieshammer S; Hetzel M; Hetzel J; Kochs M; Hombach V
Br Heart J; 1993 Jul; 70(1):17-21. PubMed ID: 8037993
[TBL] [Abstract][Full Text] [Related]
38. [The antianginal activity of angiotensin-converting enzyme inhibitors].
Cherevatov BG; Shelest AN
Lik Sprava; 1997; (5):50-3. PubMed ID: 9491696
[TBL] [Abstract][Full Text] [Related]
39. Captopril in heart failure. A double blind controlled trial.
Cleland JG; Dargie HJ; Hodsman GP; Ball SG; Robertson JI; Morton JJ; East BW; Robertson I; Murray GD; Gillen G
Br Heart J; 1984 Nov; 52(5):530-5. PubMed ID: 6388612
[TBL] [Abstract][Full Text] [Related]
40. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure.
Cleland JG; Henderson E; McLenachan J; Findlay IN; Dargie HJ
J Am Coll Cardiol; 1991 Mar; 17(3):733-9. PubMed ID: 1993795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
